| MeSH term | MeSH ID | Detail |
|---|---|---|
| Tay-Sachs Disease | D013661 | 2 associated lipids |
| Short Bowel Syndrome | D012778 | 3 associated lipids |
| Shock, Hemorrhagic | D012771 | 4 associated lipids |
| Gastroesophageal Reflux | D005764 | 10 associated lipids |
| Fetal Resorption | D005327 | 15 associated lipids |
| Pancreatitis, Acute Necrotizing | D019283 | 18 associated lipids |
| Cholestasis | D002779 | 23 associated lipids |
| Birth Weight | D001724 | 23 associated lipids |
| Colitis, Ulcerative | D003093 | 24 associated lipids |
| Gastrointestinal Hemorrhage | D006471 | 27 associated lipids |
Taurodeoxycholic acid
Taurodeoxycholic acid is a lipid of Sterol Lipids (ST) class. Taurodeoxycholic acid is associated with abnormalities such as Ischemia and Wiskott-Aldrich Syndrome. The involved functions are known as Cell Proliferation, Transcriptional Activation, Phosphorylation, Anabolism and Biochemical Pathway. Taurodeoxycholic acid often locates in Body tissue, Epithelium, Blood, Mucous Membrane and Hepatic. The associated genes with Taurodeoxycholic acid are NOX5 gene, GPBAR1 gene, NR1H4 gene and SLC33A1 gene. The related lipids are cholanic acid, taurolithocholic acid 3-sulfate, Sterols, 7-dehydrocholesterol and tauromuricholic acid.
Cross Reference
Introduction
To understand associated biological information of Taurodeoxycholic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Taurodeoxycholic acid?
Taurodeoxycholic acid is suspected in Ischemia and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Taurodeoxycholic acid
PubChem Associated disorders and diseases
What pathways are associated with Taurodeoxycholic acid
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Taurodeoxycholic acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Taurodeoxycholic acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Taurodeoxycholic acid?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Taurodeoxycholic acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Taurodeoxycholic acid?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Taurodeoxycholic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Lee HK et al. | Bile Acid Inhibition of N-type Calcium Channel Currents from Sympathetic Ganglion Neurons. | 2012 | Korean J. Physiol. Pharmacol. | pmid:22416216 |
| Renga B et al. | Discovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasis. | 2012 | PLoS ONE | pmid:22291955 |
| Lodola A et al. | A catalytic mechanism for cysteine N-terminal nucleophile hydrolases, as revealed by free energy simulations. | 2012 | PLoS ONE | pmid:22389698 |
| Studer E et al. | Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes. | 2012 | Hepatology | pmid:21932398 |
| Karlgren M et al. | In vitro and in silico strategies to identify OATP1B1 inhibitors and predict clinical drug-drug interactions. | 2012 | Pharm. Res. | pmid:21861202 |
| Zhang Y et al. | Dysfunction of organic anion transporting polypeptide 1a1 alters intestinal bacteria and bile acid metabolism in mice. | 2012 | PLoS ONE | pmid:22496825 |
| Kumar M et al. | Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases. | 2012 | Exp Diabetes Res | pmid:22611376 |
| Okoli AS et al. | Effects of human and porcine bile on the proteome of Helicobacter hepaticus. | 2012 | Proteome Sci | pmid:22533459 |
| Karmakar S et al. | TLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasis. | 2012 | PLoS Pathog. | pmid:22511870 |
| Zahiri HR et al. | Bile salt supplementation acts via the farnesoid X receptor to alleviate lipopolysaccharide-induced intestinal injury. | 2011 | Surgery | pmid:21878234 |